Summary

3.57 0.02(0.42%)07/05/2024
Accolade Inc (ACCD)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
0.42-42.24-47.33-62.02-68.48-73.050.00-88.03


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close3.57
Open3.57
High3.64
Low3.52
Volume854,471
Change0.02
Change %0.42
Avg Volume (20 Days)2,291,820
Volume/Avg Volume (20 Days) Ratio0.37
52 Week Range3.48 - 15.36
Price vs 52 Week High-76.79%
Price vs 52 Week Low2.44%
Range-0.42
Gap Up/Down-0.04
Fundamentals
Market Capitalization (Mln)284
EBIDTA0
PE Ratio0.0000
PEG Ratio0.0000
WallStreet Target Price52.00
Book Value11.0560
Earnings Per Share-2.6530
EPS Estimate Current Quarter-0.5600
EPS Estimate Next Quarter0.0000
EPS Estimate Current Year-1.9400
EPS Estimate Next Year-0.8600
Diluted EPS (TTM)-2.6530
Revenues
Profit Marging-0.5744
Operating Marging (TTM)-0.4368
Return on asset (TTM)-0.0819
Return on equity (TTM)-0.2861
Revenue TTM230,491,008
Revenue per share TTM4.6190
Quarterly Revenue Growth (YOY)0.9920
Quarterly Earnings Growth (YOY)0.0000
Gross Profit (TTM)76,685,000
Dividends
Dividend Share0.0000
Dividend Yield
Valuations
Trailing PE0.0000
Forward PE0.0000
Price Sales (TTM)0.0000
Price Book (MRQ)2.2238
Revenue Enterprise Value 6.6255
EBITDA Enterprise Value0.0000
Shares
Shares Outstanding66,664,200
Shares Float56,637,226
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.00
Insider (%)3.67
Institutions (%)73.23


07/03 11:30 EST - accesswire.com
Accolade, Inc Investors Are Invited To Participate In The Securities Fraud Probe Of ACCD With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
07/02 13:15 EST - accesswire.com
Investors In ACCD Can Join The Securities Fraud Investigation Of Accolade, Inc
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
06/28 09:08 EST - benzinga.com
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.2% on Friday.
06/28 08:04 EST - barrons.com
Accolade Stock Sinks After Earnings. The Case to Buy the Dip.
The tech and health company's fiscal-year earnings report weighs on shares.
06/28 07:15 EST - seekingalpha.com
Accolade: Mixed Guidance (Rating Downgrade)
Accolade's full-year guidance was mixed, notwithstanding a Q1 FY 2025 results beat driven by a favorable timing factor. ACCD sees its revenue growth slowing from +14% last year to +13% in the current fiscal year, but its 3.7% FY 2025 EBITDA margin guidance was above expectations. My rating for Accolade is downgraded from a Buy to a Hold, after considering the company's outlook in light of its updated guidance.
06/27 21:16 EST - businesswire.com
ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm.
06/27 19:24 EST - seekingalpha.com
Accolade, Inc. (ACCD) Q1 2025 Earnings Call Transcript
Accolade, Inc. (NASDAQ:ACCD ) Q1 2025 Earnings Conference Call June 27, 2024 4:30 PM ET Company Participants Todd Friedman - SVP of IR Rajeev Singh - CEO Steve Barnes - CFO Conference Call Participants Richard Close - Canaccord Genuity Craig Hettenbach - Morgan Stanley Michael Cherny - Leerink Partners Jeff Garro - Stephens Inc. Ryan Daniels - William Blair Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Ryan MacDonald - Needham & Company Stephanie Davis - Barclays Stan Berenshteyn - Wells Fargo David Larsen - BTIG Jack Wallace - Guggenheim Securities Operator Hello, and thank you for standing by. Welcome to the Accolade First Quarter 2025 Earnings Results Conference Call.
06/27 18:16 EST - zacks.com
Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates
Accolade (ACCD) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.52 per share a year ago.
06/27 16:03 EST - globenewswire.com
Accolade Announces Results for Fiscal First Quarter 2025
SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2024.
06/12 08:00 EST - globenewswire.com
Accolade to Announce Fiscal First Quarter 2025 Financial Results
SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first quarter 2025 financial results on Thursday, June 27, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.
05/21 09:00 EST - prnewswire.com
Accolade Welcomes Noom to Trusted Partner Ecosystem
The partnership combines Noom's best-in-class content and coaching with Accolade's advanced primary care physicians SEATTLE , May 21, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today that Noom has joined Accolade's Trusted Partner Ecosystem to provide customers with a comprehensive solution for weight loss and metabolic health, including support for GLP-1s and other anti-obesity medications. In addition to the standard integrated features that drive appropriate Trusted Partner utilization, Noom's clinical obesity management solution, Noom Med, will be powered by Accolade physicians extensively trained in weight loss protocols and advanced primary care.
05/10 11:45 EST - fool.com
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Wood added to her positions in Roblox, Accolade, and Intellia Therapeutics on Thursday. Roblox had a decent first quarter, but weak guidance sent the shares more than 20% lower on Thursday.
04/25 23:29 EST - seekingalpha.com
Accolade, Inc. (ACCD) Q4 2024 Earnings Call Transcript
Accolade, Inc. (NASDAQ:ACCD ) Q4 2024 Earnings Conference Call April 25, 2024 4:30 PM ET Company Participants Todd Friedman - Senior Vice President of Investor Relations Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Conference Call Participants Jailendra Singh - Trust Securities Stephanie Davis - Barclays Ryan Daniels - William Blair Michael Cherny - Leerink Partners Richard Close - Canaccord Genuity Craig Hettenbach - Morgan Stanley Jeff Garro - Stephens Ryan MacDonald - Needham & Company Jessica Tassan - Piper Sandler David Larsen - BTIG Stanislav Berenshteyn - Wells Fargo Operator Hello and thank you for standing by. Welcome to Accolade Fourth Quarter 2024 Earnings Results Conference Call.
04/25 18:16 EST - zacks.com
Accolade (ACCD) Reports Q4 Loss, Tops Revenue Estimates
Accolade (ACCD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.42 per share a year ago.
04/25 16:03 EST - globenewswire.com
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
SEATTLE, April 25, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal fourth quarter and full year ended February 29, 2024.
04/05 06:34 EST - seekingalpha.com
Accolade: Staying Bullish On Favorable Developments
I like Accolade's choice of new partners added year-to-date, as I think the services provided by these partners will be well received by its clients' employees. ACCD's latest "Artificial Intelligence Excellence Award" presented by the Business Intelligence Group provides a validation of the potential AI-related tailwinds for the company. A review of Accolade's most recent developments leaves me bullish on the stock.
03/20 09:00 EST - prnewswire.com
Accolade Wins 2024 Artificial Intelligence Excellence Award
Award recognizes the innovative blend of AI technology with an empathetic human approach to deliver exceptional healthcare experiences for members SEATTLE , March 20, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) today announced it has been named a winner of the Business Intelligence Group's Artificial Intelligence Excellence Awards program for its application of Natural Language Processing. This award recognizes companies leveraging AI technology to solve real-world problems.
03/19 15:00 EST - businesswire.com
National Accolade Bestowed on Arkansas-Based Provider: ‘Best Rural High Speeds'
LITTLE ROCK, Ark.--(BUSINESS WIRE)--In an industry where connection and quality of service matter most, Arkansas-based Kinetic was recognized and honored by Forbes Home for its “Best Rural High Speeds” in the recent article “Best Internet Options for Rural Areas of 2024.” This Forbes Home accolade is a testament to Kinetic's pledge to bring affordable, fast and reliable internet to rural areas. Kinetic was selected by a team of Forbes Home licensed professionals comparing 38 attributes across 2.
03/19 09:00 EST - prnewswire.com
Accolade Promotes Kelsi McDonald Harris to Chief People Officer
McDonald Harris assumes new role on Executive Leadership Team to deliver an exceptional employee experience and support the growth and development of its 2,400+ global workforce SEATTLE , March 19, 2024 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) announced today the promotion of Kelsi McDonald Harris as Chief People Officer and Senior Vice President. "Transforming healthcare in this country requires visionary human resources leaders who are willing to challenge the status quo," said Rajeev Singh, Chairman and CEO at Accolade.
03/12 08:56 EST - proactiveinvestors.com
Chesapeake Bank receives AARP accolade for combatting financial exploitation
Chesapeake Financial Shares Inc. (OTCQX:CPKF)'s Chesapeake Bank was honored by the American Association of Retired Persons (AARP) for its steadfast efforts in combatting financial exploitation. On March 6, AARP revealed the recognition of Chesapeake Bank among a cohort of 166 banks, credit unions, and financial advisory firms bestowed with the prestigious BankSafe Trained Seal.